NDC 80425-0595-01 - GABAPENTIN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0595
- Requested NDC
- 80425-0595-01
- Package NDCs from labels
- 80425-0595-1, 80425-0595-2, 80425-0595-3, 80425-0595-4, 80425-0595-01
- Manufacturer
- Advanced Rx of Tennessee, LLC
- Effective date
- 2026-09-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| GABAPENTIN - Advanced Rx of Tennessee, LLC | Advanced Rx of Tennessee, LLC | 2026-09-11 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | Direct_Rx | 0b286fd1-8179-d87a-e063-6294a90a2f23 | 2026-03-05 | Warnings, Adverse reactions | 310432 6CW7F3G59X |
| cle de peau BEAUTE RADIANT FLUID FOUNDATION NATURAL B50 | OCTINOXATE AND TITANIUM DIOXIDE | SHISEIDO AMERICAS CORPORATION | 4490f968-46b6-44d2-af2d-5130b52c8861 | 2026-03-05 | Warnings | 15FIX9V2JP |
| Isopropyl alcohol 91 percent ReadyInCase | ISOPROPYL ALCOHOL | P & L Development, LLC | a6d2068f-705d-4341-b1c8-81e1b563ab9a | 2026-03-04 | Warnings | ND2M416302 |
| 50% Isopropyl Alcohol | ISOPROPYL ALCOHOL | Amazon.com Services LLC | 95e31119-8487-4bc9-b1c2-c43d32fc80ce | 2026-03-03 | Warnings, Adverse reactions | ND2M416302 |
| Gabapentin | GABAPENTIN | American Health Packaging | e00f5048-1a06-44f4-b244-aa2755f4be22 | 2026-03-02 | Warnings, Adverse reactions | 6CW7F3G59X |
| Isopropyl | ISOPROPYL ALCOHOL | Old East Main Co. | ea6f3065-780e-4afc-a361-a2cb296ae4d5 | 2026-03-02 | Warnings, Adverse reactions | ND2M416302 |
| 70% | ISOPROPYL ALCOHOL | Old East Main Co. | 3e7a7f3e-3e99-4999-95c2-1603aca08e89 | 2026-03-02 | Warnings, Adverse reactions | ND2M416302 |
| 50% Rubbing | ISOPROPYL ALCOHOL | Old East Main Co. | 2b600254-2a70-4254-85fb-29b9adb56c9a | 2026-03-02 | Warnings, Adverse reactions | ND2M416302 |
| Isopropyl alcohol 91 percent | ISOPROPYL ALCOHOL | TARGET Corporation | c49f46c5-f9b2-4045-a31d-63cb22210233 | 2026-03-02 | Warnings | ND2M416302 |
| Isopropyl alcohol 91 percent | ISOPROPYL ALCOHOL | Sam's West, Inc | a9d6778a-e5ad-4e02-9142-4a932540eda7 | 2026-03-02 | Warnings | ND2M416302 |
| Gabapentin | GABAPENTIN | Solco Healthcare US, LLC | 360d953b-4313-45ae-b933-296547d4577d | 2026-02-28 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | United Natural Foods, Inc. dba UNFI | 4eee73dd-039e-44a5-b380-21ff32efee22 | 2026-02-26 | Warnings, Adverse reactions | ND2M416302 |
| 70% | ISOPROPYL ALCOHOL | United Natural Foods, Inc. dba UNFI | d39bc652-442d-4d91-9eba-a496636b9533 | 2026-02-26 | Warnings, Adverse reactions | ND2M416302 |
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | United Natural Foods, Inc. dba UNFI | f6be70d5-763c-42d8-9b4e-a55e84c74785 | 2026-02-26 | Warnings, Adverse reactions | ND2M416302 |
| CLE DE PEAU BEAUTE RADIANT FLUID FOUNDATION MATTE M B10 | TITANIUM DIOXIDE | Shiseido Americas Corporation | 54f8210f-4934-4ada-89c3-aa89e7a09260 | 2026-02-26 | Warnings | 15FIX9V2JP |
| SHISEIDO UV PROTECTIVE COMPACT (REFILL) FAIR IVORY | OCTINOXATE, OCTOCRYLENE, AND TITANIUM DIOXIDE | SHISEIDO AMERICAS CORPORATION | c05cef12-a6a7-4682-9357-6d77f4ca3267 | 2026-02-25 | Warnings | 15FIX9V2JP |
| cle de peau BEAUTE RADIANT FOUNDATION N M I10 | OCTINOXATE AND TITANIUM DIOXIDE | Shiseido Americas Corporation | 3be1fe06-bd3b-4078-bee9-d3caf8d068ff | 2026-02-25 | Warnings | 15FIX9V2JP |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | 54c09aa5-6724-480a-a115-c88484e39e93 | 2026-02-24 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Advagen Pharma Ltd | 401b30fc-e143-4906-aae1-e5b5c190d4a8 | 2026-02-24 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Advagen Pharma Ltd | bfee67dc-d2b1-4a00-92d9-a42be3189c74 | 2026-02-24 | Warnings, Adverse reactions | 6CW7F3G59X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.